Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hazard Rate01:11

Hazard Rate

151
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
151
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

613
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
613
Routh-Hurwitz Criterion II01:19

Routh-Hurwitz Criterion II

319
In the application of the Routh-Hurwitz criterion, two specific scenarios can arise that complicate stability analysis.
The first scenario occurs when a singular zero appears in the first column of the Routh table. This situation creates a division by zero issues. To resolve this, a small positive or negative number, denoted as epsilon (∈), is substituted for the zero. The stability analysis proceeds by assuming a sign for ∈. If ∈ is positive, any sign change in the first...
319
Estimation of the Physical Quantities01:05

Estimation of the Physical Quantities

4.6K
On many occasions, physicists, other scientists, and engineers need to make estimates of a particular quantity. These are sometimes referred to as guesstimates, order-of-magnitude approximations, back-of-the-envelope calculations, or Fermi calculations. The physicist Enrico Fermi was famous for his ability to estimate various kinds of data with surprising precision. Estimating does not mean guessing a number or a formula at random. Instead, estimation means using prior experience and sound...
4.6K
Design Consideration01:22

Design Consideration

253
Designing a structure involves a series of considerations, primarily the material's ultimate strength, calculated through tests that measure changes under increased force until the material reaches its breaking point or limit. The ultimate load, where the material breaks, is divided by its original cross-sectional area, resulting in the ultimate normal stress or strength. The ultimate shearing stress is another significant factor taken into account.
The factor of safety is another key...
253
Econometric Views (EViews)01:29

Econometric Views (EViews)

192
Econometric Views, often stylized as EViews, is a package that merges statistical analysis with econometric studies. It is designed to provide tools for time series analysis, forecasting, and econometric model simulation. The software originated from MicroTSP software and has evolved significantly since its inception in 1981. The history of EViews is marked by a continuous effort to enhance its computational speed and user interface. It was initially developed for large computing systems but...
192

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tensile strain switched ferromagnetism in layered NbS2 and NbSe2.

ACS nano·2012
Same author

Synthesis of near-infrared-emitting CdTeSe and CdZnTeSe quantum dots.

Luminescence : the journal of biological and chemical luminescence·2012
Same author

Renal tolerability of iopromide and iodixanol in 562 renally impaired patients undergoing cardiac catheterisation: the DIRECT study.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·2012
Same author

Removal of FePO4 and Fe3(PO4)2 crystals on the surface of passive fillers in Fe0/GAC reactor using the acclimated bacteria.

Journal of hazardous materials·2012
Same author

Decorating PtCo bimetallic alloy nanoparticles on graphene as sensors for glucose detection by catalyzing luminol chemiluminescence.

Small (Weinheim an der Bergstrasse, Germany)·2012
Same author

Photoluminescent enhancement of CdSe/Cd(1-x) Zn(x)S quantum dots by hexadecylamine at room temperature.

Journal of nanoscience and nanotechnology·2012

Related Experiment Video

Updated: Aug 6, 2025

Data Acquisition Protocol for Determining Embedded Sensitivity Functions
07:46

Data Acquisition Protocol for Determining Embedded Sensitivity Functions

Published on: April 20, 2016

6.2K

Application of estimand framework in ICH E9 (R1) to safety evaluation.

Xuelong Wang1, Ping Yang2, Shuai S Yuan3

  • 1BARDS, Merck & Co, Rahway, New Jersey, USA.

Journal of Biopharmaceutical Statistics
|March 23, 2023
PubMed
Summary

This study extends the estimand framework beyond efficacy to safety assessments in clinical trials. It explores applications in oncology and discusses adapting safety estimands for pandemic-related challenges like COVID-19.

Keywords:
Safetyestimand frameworkintercurrent eventsoncology trialpooled data analysis

More Related Videos

Design and Application of a Fault Detection Method Based on Adaptive Filters and Rotational Speed Estimation for an Electro-Hydrostatic Actuator
06:45

Design and Application of a Fault Detection Method Based on Adaptive Filters and Rotational Speed Estimation for an Electro-Hydrostatic Actuator

Published on: October 28, 2022

1.7K
Evaluation of an Exclusive Spur Dike U-Turn Design with Radar-Collected Data and Simulation
11:41

Evaluation of an Exclusive Spur Dike U-Turn Design with Radar-Collected Data and Simulation

Published on: February 1, 2020

20.5K

Related Experiment Videos

Last Updated: Aug 6, 2025

Data Acquisition Protocol for Determining Embedded Sensitivity Functions
07:46

Data Acquisition Protocol for Determining Embedded Sensitivity Functions

Published on: April 20, 2016

6.2K
Design and Application of a Fault Detection Method Based on Adaptive Filters and Rotational Speed Estimation for an Electro-Hydrostatic Actuator
06:45

Design and Application of a Fault Detection Method Based on Adaptive Filters and Rotational Speed Estimation for an Electro-Hydrostatic Actuator

Published on: October 28, 2022

1.7K
Evaluation of an Exclusive Spur Dike U-Turn Design with Radar-Collected Data and Simulation
11:41

Evaluation of an Exclusive Spur Dike U-Turn Design with Radar-Collected Data and Simulation

Published on: February 1, 2020

20.5K

Area of Science:

  • Clinical Trials Methodology
  • Pharmacovigilance
  • Biostatistics

Background:

  • The International Council for Harmonisation E9 (R1) guideline introduced the estimand framework to align clinical study components with research questions.
  • Current applications of the estimand framework primarily focus on efficacy, with limited attention to safety evaluations.
  • A clear definition of study objectives is crucial for the integrity and interpretation of clinical research.

Purpose of the Study:

  • To adapt and expand the estimand framework for safety assessments in clinical trials.
  • To compare and contrast the attributes of safety and efficacy estimands.
  • To explore the practical applications of safety estimands in oncology trials and pooled analyses, including considerations for global health events such as the COVID-19 pandemic.

Main Methods:

  • Review and adaptation of the existing ICH E9 (R1) estimand framework for safety contexts.
  • Comparative analysis of safety and efficacy estimand attributes.
  • Illustrative case studies and discussion of applications in oncology and pandemic scenarios.

Main Results:

  • The estimand framework can be effectively extended to define and structure safety assessments.
  • Key differences and similarities between safety and efficacy estimands were identified, highlighting the unique considerations for safety.
  • The framework provides a structured approach to address safety evaluation challenges, including those posed by external factors like the COVID-19 pandemic.

Conclusions:

  • The expanded estimand framework offers a robust methodology for defining safety objectives in clinical research.
  • Application of safety estimands enhances the clarity and rigor of safety evaluations, particularly in complex settings like oncology and during public health crises.
  • This approach supports more consistent and interpretable safety assessments across studies and populations.